PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
22-Sep-2025 NEUPATH HEALTH TO PRESENT AT THE ANNUAL SMALLCAP DISCOVERIES CONFERENCE IN VANCOUVER Businesswire
22-Sep-2025 Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer Businesswire
22-Sep-2025 Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase 2 Clinical Trial of SAT-3247 in Children with Duchenne Muscular Dystrophy Businesswire
22-Sep-2025 Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease Businesswire
22-Sep-2025 SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots Businesswire
22-Sep-2025 TME Pharma Announces Date of Publication of Half Year Results and CEO Share Purchase Businesswire
22-Sep-2025 Abselion Introduces Protein G Total Antibody Quantification Kit Abselion
22-Sep-2025 Medincell: New Data Show that UZEDY® Initiation in Hospitalized Patients is Associated with Faster Discharge and an Overall Clinician Preference Compared to Invega Sustenna® Businesswire
22-Sep-2025 Medincell: New Pivotal Phase 3 Long-Term Data Supports Olanzapine Long-Acting Injectable (LAI) with Favorable Safety Profile – No PDSS Observed Businesswire
22-Sep-2025 Positive Phase III Results Show Genentech’s Giredestrant Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer Businesswire
22-Sep-2025 Aelis Farma Reports 2025 Half-Year Financial Results and Presents Progress and Development Outlook Businesswire
20-Sep-2025 Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Businesswire
20-Sep-2025 FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab) Businesswire
19-Sep-2025 Advicenne Reports First Half Financial Results as of June 30, 2025, and Updates on Its Activities Businesswire
19-Sep-2025 JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program Businesswire
19-Sep-2025 Candid Therapeutics Recognized as a 2025 Endpoints 11 Honoree Businesswire
19-Sep-2025 No Difference in Transplant Outcomes Seen for Patients Unlikely to Find a Matched Unrelated Donor When a Donor Search Prognosis Strategy is Used Businesswire
19-Sep-2025 xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery Businesswire
19-Sep-2025 Asia-Pacific Robotic Neurosurgery Research and Forecast Report 2025-2035 | Rapid Expansion Fueled by Healthcare Infrastructure Throughout Emerging APAC Markets - ResearchAndMarkets.com Businesswire
19-Sep-2025 KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema Businesswire